CONTROLLED TRIAL OF AZTREONAM VS TOBRAMYCIN AND AZLOCILLIN FOR ACUTE PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS

被引：36

作者：

BOSSO, JA ^{[1
]}

BLACK, PG ^{[1
]}

机构：

[1] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1988年 / 7卷 / 03期

关键词：

D O I：

10.1097/00006454-198803000-00008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：171 / 176

页数：6

共 33 条

[1] IMMUNOLOGY OF THE MONOBACTAM AZTREONAM [J].

ADKINSON, NF ;

SWABB, EA ;

SUGERMAN, AA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :93-97

[2]

Adkinson NF, 1985, REV INFECT DIS S4, V7, P613

[3]

ARONOFF SC, 1984, ANTIMICROB AGENTS CH, V25, P279, DOI 10.1128/AAC.25.2.279

[4]

BARRY AL, 1985, REV INFECT DIS S4, V7, P594

[5]

BAUER AW, 1966, AM J CLIN PATHOL, V45, P493

[6] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J].

BEAUDRY, PH ;

MARKS, MI ;

MCDOUGALL, D ;

DESMOND, K ;

RANGEL, R .

JOURNAL OF PEDIATRICS, 1980, 97 (01) :144-147

[7] EFFICACY OF AZTREONAM IN PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS [J].

BOSSO, JA ;

BLACK, PG ;

MATSEN, JM .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (04) :393-397

[8]

BOSSO JA, 1987, CLIN PHARMACY, V6, P54

[9] PHARMACOKINETICS AND DOSAGE REQUIREMENTS OF NETILMICIN IN CYSTIC-FIBROSIS PATIENTS [J].

BOSSO, JA ;

TOWNSEND, PL ;

HERBST, JJ ;

MATSEN, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) :829-831

[10] INVITRO ACTIVITY OF AZTREONAM COMBINED WITH TOBRAMYCIN AND GENTAMICIN AGAINST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA AND PSEUDOMONAS-CEPACIA FROM PATIENTS WITH CYSTIC-FIBROSIS [J].

BOSSO, JA ;

SAXON, BA ;

MATSEN, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1403-1405

← 1 2 3 4 →